Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
03/2005
03/16/2005CN1593594A Chinese traditional medicinal composition and its preparation process and usage
03/16/2005CN1593582A Bitter free gingko leaf product and its preparation process
03/16/2005CN1593574A Chinese medicinal preparation for treating cardiovascular and cerebrovascular diseases and its preparing process
03/16/2005CN1593571A Chinese traditional medicine for treating hypertension
03/16/2005CN1593566A Hemiplegia treating pill
03/16/2005CN1593562A Ginkgo leaf extract composition
03/16/2005CN1593537A Angitis treating capsule
03/16/2005CN1593510A Method for preparing Chinese medicinal formulation of dog button
03/16/2005CN1593505A Quick acting and heart resurrecting oral disintegrating tablet and its preparation process
03/16/2005CN1593503A Effective extract of Chinese silkuine bark with cardotonic function and its preparing process and uasge
03/16/2005CN1593489A Traditional Chinese Medicinal formulation for treating coronary heart disease and preparation method thereof
03/16/2005CN1593485A Formulation for treating coronary heart disease and angina pectoris and its preparing process
03/16/2005CN1593480A Fig buccal tablet and its preparing process
03/16/2005CN1593479A Medicinal plaster for treating angiocardiopathy
03/16/2005CN1593470A Compound linolenic acid preparation
03/16/2005CN1593454A Magnesium, potassium and calcium mixture and its usage
03/16/2005CN1593452A Compound capsule of amino acid and chitosan
03/16/2005CN1593449A self emulsifying soft capsule of breviscapine and its preparation
03/16/2005CN1593446A Breviscapine contained prescription for treating cardiovascular and cerebrovascular diseases
03/16/2005CN1593445A Prescription drug for treating cardiovascular and cerebrovascular diseases
03/16/2005CN1593444A Prescription drug for treating cardiovascular and cerebrovascular diseases
03/16/2005CN1593442A Application of 20(S)-ginsenoside-Rg#[3] in the preparing process of medicine for treating or preventing cardiovascular and cerebrovascular disease
03/16/2005CN1593441A Application of 20(S)-ginsenoside-Rg#[3] in the preparing process of medicine for treating or preventing cerebrovascular disease
03/16/2005CN1593440A Orally disintegrating tablet of
03/16/2005CN1593439A Orally disintegrating tablet of notoginsen total saponins and its preparation
03/16/2005CN1593434A Method for preparing freeze dried powder injection of rhodiola root
03/16/2005CN1593428A Dextran-aspirin combined medicine and its preparation method
03/16/2005CN1593420A Ginkoleaf extract and diphyridamole powder injection and its preparation
03/16/2005CN1593419A Urapidil large volume injection, its preparation method and application
03/16/2005CN1593418A Flunarizine hydrochloride soft capsule and its preparation method
03/16/2005CN1593415A Medicine for preventing and treating stiff lump caused by phlebitis and injection
03/16/2005CN1593412A Method for preparing nimodipine carrying float sustained release mini capsule
03/16/2005CN1593410A Dripping pills for treating cardiac arrhythmia and its preparation
03/16/2005CN1593398A Daidzein dispersible tablet composition and its preparation process
03/16/2005CN1593397A Daidzein soft capsule and its preparation process
03/16/2005CN1593394A Sustained release preparation of phenoprolamine hydrochloride and its preparing process
03/16/2005CN1593392A Freeze dried powder injection of coenzyme Q10 and its preparation process
03/16/2005CN1193026C Z-pyrazoline-5-ones
03/16/2005CN1193025C Novel 1, 3-dihydro-2H-indol-2-one derivatives, their preparing method and pharmceutical composition containing the same
03/16/2005CN1193014C Novol pyrrole sulphamide compound
03/16/2005CN1193003C Aminobenzophenones as inhibitors of IL-1 beta and TNF-alpha
03/16/2005CN1193000C Biphenyl derivatives substituted by an aromatic or heteroaromatic radical and pharmaceutical and cometic compositions containing same
03/16/2005CN1192793C Heart failure resisting Chinese medicine
03/16/2005CN1192782C Production method of injection used fortreating cardio and cerebro vascular diseases and its product
03/16/2005CN1192767C Capsule and binding agent for pharmaceutical formulations with improved storage stability
03/15/2005US6867225 Alpha type human peroxisome proliferator activated receptor agonists; such as 2-methyl-2-(3-methyl-4-(((4-phenoxymethyl-2-(4-trifluoromethylphenyl) -thiazol-5-yl-carbonyl)-amino)-methyl)phenoxy)propionic acid
03/15/2005US6867224 Thiazole or oxazole derivatives such as 5-(4-Methyl-2-(4-trifluoromethyl-phenyl)-thiazol-5-ylmethylsulfanyl)-indan-2-carboxylic acid
03/15/2005US6867222 Nociceptin analogs
03/15/2005US6867221 Cyclic amine compounds and pharmaceutical composition containing the same
03/15/2005US6867215 Cardioprotective phosphonates and malonates
03/15/2005US6867214 Quinazoline derivatives and pharmaceutical applications thereof
03/15/2005US6867213 Vitronectin receptor inhibitors; bone diseases, osteoporosis; esterification of acid form with isopropanol
03/15/2005US6867210 For treatment or prevention of neurodegenerative conditions such as amyotrophic lateral sclerosis, acute or chronic pain, as antitinnitus agents, anticonvulsants, antimanic depressants, local anesthetics, antiarrhythmics
03/15/2005US6867208 Vitronectin receptor antagonists, their preparation and their use
03/15/2005US6867205 Useful for the treatment and/or prophylaxis of diseases associated with dipeptidyl peptidase, such as diabetes, particularly non-insulin dependent diabetes mellitus, and impaired glucose tolerance
03/15/2005US6867202 Treatment of insulin resistance
03/15/2005US6867200 Anticancer agents; anticoagulants
03/15/2005US6867190 Methods of therapy with thrombin derived peptides
03/15/2005US6867184 Methods of treating diabetic cardiomyopathy using glycogen phosphorylase inhibitors
03/15/2005US6866851 GFRα1-RET specific agonists and methods therefor
03/15/2005CA2382549C Use of inhibitors of the renin-angiotensin system in the prevention of cardiovascular events
03/15/2005CA2323047C Prodrugs of benzofuranylmethyl carbamate nk, antagonists
03/15/2005CA2246595C Novel atropisomers of 2,3-disubstituted-(5,6)-heteroarylfused-pyrimidin-4-ones
03/10/2005WO2005021555A1 Bicyclic piperazine compound and use thereof
03/10/2005WO2005021541A2 Process for the production of polymorphs of rosiglitazone maleate
03/10/2005WO2005021534A1 1,3-dihydro-2h-indol-2-one derivative
03/10/2005WO2005021505A1 The claimed invention relates to novel 4-piperidinecarboxamide and the use thereof for the preparation of medicaments against 5-ht2a receptor-related disorders
03/10/2005WO2005021492A1 Pentafluorosulfanyl phenyl-substituted benzoylguanidines, method for their production, their use as medicaments or diagnostic agents and medicament containing said compounds
03/10/2005WO2005021486A1 Ester derivative and medicinal use thereof
03/10/2005WO2005021481A1 N, n’-dibenzyl ethylenediamine salt pf 2-(alpha-hidroxypentyl) benzoic acid and its preparing process and usage
03/10/2005WO2005021039A1 Combination of cicletanine and an oral antidiabetic and/or blood lipid-lowering agent for treating diabetes and metabolic syndrome
03/10/2005WO2005021006A1 Method and substance for facilitating weaning, reducing morbidity and reducing mortality in cardiac surgeries involving extra-corporal circulation
03/10/2005WO2005021003A2 Immunosuppressive effects of pteridine derivatives
03/10/2005WO2005021002A1 Pharmaceutical formulation comprising a pyrimidine-a-one derivative coated with an enteric polymer
03/10/2005WO2005020996A1 Method of stabilizing lipid-rich plaque and method of preventing rupture thereof
03/10/2005WO2005020992A1 Novel medical use of selective cb1-receptor antagonists
03/10/2005WO2005020974A1 Novel use of a polyamine-poor composition for the production of a medical human food
03/10/2005WO2005007192A3 Cytoprotection through the use of hif hydroxylase inhibitors
03/10/2005WO2004108062A3 Prophylaxis and/or treatment of portal hypertension
03/10/2005WO2004041794A8 Antiinflammatory 3-arylthio-3-thiazolyl-alkylamines
03/10/2005WO2004003166A3 Antibodies and uses thereof
03/10/2005WO2003104260A3 Pharmaceutical formulation
03/10/2005WO2003103475A3 Prevention and reduction of blood loss
03/10/2005WO2003093409A3 Promoters exhibiting endothelial cell specificity and methods of using same
03/10/2005WO2003092720A8 A combination product comprising an anti-coagulant and anti-arrhythmic oxabispidenes
03/10/2005WO2003073062A3 Reagents and methods for identifying and modulating expression of genes regulated by cdk inhibitors
03/10/2005WO2002087604A8 Preparations containing a combination of vitamin e and afamin
03/10/2005WO2001066772A9 Heparinase iii and uses thereof
03/10/2005US20050054851 Pyrrolo pyrimidines as agents for the inhibition of cystein proteases
03/10/2005US20050054827 Conotoxin amino acid sequences for use as tool in controlling pain; immunotherapy; mimetics
03/10/2005US20050054729 Combined with a statin, ACE-inhibitor, PDE V-inhibitor, Ca-antagonist, beta-blocker, arginine, or tetrahydrobiopterin; treating of conditions including cardiovascular disorders, erectile dysfunction, therapy and prophylaxis of diabetes including its complicatons, and respiratory diseases
03/10/2005US20050054712 Dihydroindol-2-one derivatives as steroid hormone nuclear receptor modulators
03/10/2005US20050054706 N-substituted pyrroles, pyrazoles, imidazoles, triazoles and tetrazoles used for treating and preventing cancer, inflammation, autoimmune diseases, respiratory system disorders, septic shock, pain, preterm labor, as dietetics and sexual disorders, and disorders associated with MAP kinases
03/10/2005US20050054692 secondary carbocyclic amides such as N-(4-methylcyclohexyl)-2-(4-pyridylmethyl)amino)benzoic acid amide, used as tyrosine kinase inhibitors, for treating diseases caused by persistent angiogenesis
03/10/2005US20050054674 Activator of peroxisome proliferator-activated receptor
03/10/2005US20050054671 Derivatives of alpha-phenylthiocarboxylic and $g(a)-phenyloxy-carboxylic acids useful for the treatment of diseases responding to pparalpha activation
03/10/2005US20050054668 Antagonists of MCP-1 function and methods of use thereof
03/10/2005US20050054656 Therapy for obesity, eating disorders, psychological disorders, antidepressants, central nervous system disorders
03/10/2005US20050054637 Prophylaxis, therapy cardiovascular disorders
03/10/2005US20050054631 Substituted indoles as inhibitors of poly (ADP-ribose) polymerase (PARP)
1 ... 803 804 805 806 807 808 809 810 811 812 813 814 815 816 817 818 819 820 821 822 823 ... 1595